Comment on: "Tumour-agnostic drugs in paediatric cancers", Chisholm et al., BJC 2020
Br J Cancer
.
2021 Jan;124(2):524-526.
doi: 10.1038/s41416-020-01103-0.
Epub 2020 Oct 1.
Authors
Thomas Richard William Oliver
1
2
,
Thomas John Jackson
3
4
,
Olumide Ogunbiyi
3
,
Neil Sebire
3
4
,
Olga Slater
3
,
Mette Jorgensen
5
,
Sam Behjati
6
7
8
Affiliations
1
Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
2
Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
3
Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
4
UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK.
5
Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
[email protected]
.
6
Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
[email protected]
.
7
Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
[email protected]
.
8
Department of Paediatrics, University of Cambridge, Cambridge, CB2 0QQ, UK.
[email protected]
.
PMID:
32999471
PMCID:
PMC7852543
DOI:
10.1038/s41416-020-01103-0
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Child
Humans
Neoplasms* / drug therapy
Pharmaceutical Preparations*
Substances
Pharmaceutical Preparations
Grants and funding
WT_/Wellcome Trust/United Kingdom